The Assessment of the Occurrence of Benign Hypermobility Joint Syndrome in Physiotherapy Students

The occurrence of connective tissue disorders is an important factor for development of occupational diseases in professions requiring a non-ergonomic and often static load of the musculoskeletal system. Symptoms of the connective tissue disorders appear at different ages. The diagnosis of hypermobility is an important problem due to the lack of uniform diagnostic criteria. The aim of this paper is to evaluate the incidence of joint hypermobility and its relation with a history of injuries and the level of physical activity in Physiotherapy students. The study involved 143 students (69% female, 31% male) aged 18 to 27 years (M = 20.7; SD = 1.43). The assessment of the occurrence of Benign Hypermobility Joint Syndrome (BHJS) syndrome was performed using the Beighton and Brighton scale. Among the surveyed students almost 82% of the women and just over 18% of the men fulfilled the diagnostic criteria for the diagnosis of hypermobility. A significant difference was also observed in the physical activity of the students. Among those who showed no signs of hypermobility exactly half of the participants trained sports as amateurs, while in the group of people with hypermobility the proportion was lower by nearly half. BHJS was not related to injuries and operations in the study group

Consensus on methods of development of clinical practice guidelines in oncology under the auspices of Maria Sklodowska-Curie National Research Institute of Oncology and the Agency for Health Technology Assessment and Tariff System

Introduction.As the changes leading to improvement of cancer care in Poland have shown the need to introduce clinical practice guidelines into the health care system, it has become clear that no methodological standard of the process for guidelines preparation has been established so far. The following process aims to present a unified and comprehensive clinical practice guidelines (CPGs) development methodology. Materials and methods.A review of globally recognised methods used by guideline development groups was prepared, informing the discussion during three plenary meetings and extensive consultations in writing. The resulting document was unanimously approved by a group of 24 methodologists and clinical experts, and has been formally recognized as a standard for CPGs development by the management of the National Institute of Oncology and the Agency for Health Technology Assessment and Tariff System. Results.Within the process, 43 recommendations were formulated to create unified and comprehensive rules for guideline development within the Polish healthcare system. Conclusions.The presented methods are consistent with the globally recognized tools and methods of guideline development, such as GRADE and ADAPTE, and follow quality criteria described by AGREE II. The process supports the development of high-quality guidelines within a resource-constrained setting by allowing to choose between adoption, adaptation, or de novo development of either the whole document of guidelines or particular recommendations